New Research Grants Available for Widespread Facial Disorder
BARRINGTON, Illinois (May 5, 2006) -- The National Rosacea Society today announced that new grants are available in 2006 to support research into the potential causes and other key aspects of rosacea, a chronic and often life-disruptive disorder of the facial skin and eyes, now estimated to affect 14 million Americans. The awarding of five research grants totaling $123,600 was announced earlier this year.
"High-quality studies are already yielding important new information relating to the potential etiology and pathogenesis of rosacea, and we look forward to increasing that knowledge in further studies," said Dr. Jonathan Wilkin, chairman of the NRS medical advisory board.
Application forms for research grants can be obtained by contacting the National Rosacea Society, 800 South Northwest Highway, Suite 200, Barrington, Illinois 60010, telephone 847/382-8971, fax 847/382-5567 or e-mail firstname.lastname@example.org. The deadline for submitting applications is September 15, 2006. Grants will be issued following selection by the medical advisory board.
Members of the medical advisory board include Dr. Jonathan Wilkin, chairman; Dr. Lynn Drake, Department of Dermatology, Harvard Medical School and former president of the American Academy of Dermatology (AAD); Dr. Mark Dahl, chairman of dermatology, Mayo Clinic Scottsdale and former AAD president; Dr. Richard Odom, professor of dermatology, University of California-San Francisco and former AAD president; Dr. David Norris, chairman of dermatology, University of Colorado; Dr. Frank Powell, Mater Misericordiae Hospital in Dublin, Ireland; Dr. Michael Detmar, associate professor of dermatology, Harvard Medical School; and Dr. Bryan Sires, Boyd K. Bucey Memorial Chair of Ophthalmology, University of Washington.
Because the etiology of rosacea is unknown, a high priority in awarding grants will be given to studies relating to such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of rosacea. Research in such areas as epidemiology, predisposition, quality of life and relationships with environmental and lifestyle factors may also be funded.
The National Rosacea Society is a nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting research on this widespread but little-known disorder. More information on the society's research grants program may be found at www.rosacea.org/grants/.
The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace
consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.